Marginal Zone Lymphoma
📧 Sign up to get email alerts when something new happens for Marginal Zone Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-01-13Clinical Trial Update: Local Manufacture of CAR T-Cell Products for the Treatment of B-Cell Lymphoma and B-Acute Lymphoblastic Leukemia [Phase 2]
Phase 2 clinical trial update on locally manufactured CAR T-cell products for multiple B-cell malignancies, including B-cell lymphoma and B-…
-
CLINICAL_TRIALS research · 2024-12-03Clinical Trial Update: Registry Study of Chinese Patients with Marginal Zone Lymphoma (MOTIVE)
Clinical trial registry update for a Chinese patient study on Marginal Zone Lymphoma. The study is currently recruiting.
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: MIL62 Combined With Lenalidomide Versus Lenalidomide for Patients With Rituximab Refractory Follicular Lymphoma [Phase 3]
A Phase 3 trial evaluating MIL62 in combination with Lenalidomide versus Lenalidomide alone for rituximab-refractory follicular lymphoma is …
-
CLINICAL_TRIALS research · 2024-11-20Clinical Trial Update: MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) [Phase 1, Phase 2]
A phase 1/2 clinical trial is evaluating MIL62 plus lenalidomide for relapsed/refractory indolent non-Hodgkin's lymphoma (follicular lymphom…
-
CLINICAL_TRIALS research · 2024-09-19Clinical Trial Update: Linperlisib Combination With Obinutuzumab Frontline Treatment of Marginal Zone Lymphoma Patients (MZL) [Phase 1, Phase 2]
A frontline combination of linperlisib and obinutuzumab is being studied in a Phase 1/2 trial for marginal zone lymphoma and is currently re…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2024-08-27Clinical Trial Update: ISRT 20 Gy for Indolent Localized Gastrointestinal (GI)-Lymphoma [NA]
Clinical trial update for indolent localized GI lymphomas using 20 Gy involved-site radiotherapy (ISRT); currently recruiting for gastric or…
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Oxygen Study-Orelabrutinib Combined With Obinutuzumab(O2) for First-Line Treatment of Marginal Zone Lymphoma [Phase 2]
Phase 2 trial evaluating first-line Orelabrutinib plus Obinutuzumab (O2) for Marginal Zone Lymphoma is currently recruiting.
-
CLINICAL_TRIALS research · 2024-08-22Clinical Trial Update: Significance of Duration of Maintenance Therapy With Rituximab in Non-Hodgkin Lymphomas [Phase 3]
This Phase 3 trial update discusses how the duration of rituximab maintenance therapy may affect outcomes in various non-Hodgkin lymphomas, …
-
CLINICAL_TRIALS research · 2024-07-29Clinical Trial Update: Prospective Clinical Study of Orelabrutinib in Combination With Rituximab (OR) for Primary Marginal Zone Lymphoma (MZL) That Failed or Not Suitable for Local Therapy [NA]
Prospective clinical study evaluating orelabrutinib in combination with rituximab for primary marginal zone lymphoma that failed or was not …
-
CLINICAL_TRIALS research · 2024-07-22Clinical Trial Update: Combination of Orelabrutinib and Obinutuzumab in Untreated Marginal Zone Lymphomas [Phase 2]
A Phase 2 clinical trial evaluating a combination of orelabrutinib and obinutuzumab in previously untreated marginal zone lymphoma is curren…
-
CLINICAL_TRIALS research · 2024-06-18Clinical Trial Update: Orelabrutinib Combined With Obinutuzumab and Lenalidomide (OGL Regimen) as First-line Treatment for Marginal Zone Lymphoma. [Phase 2]
This Phase 2 trial is evaluating the first-line combination of orelabrutinib with obinutuzumab and lenalidomide (OGL regimen) for marginal z…
-
CLINICAL_TRIALS research · 2024-06-11Clinical Trial Update: Clinical Study of OR for Second-line Treatment of Refractory MZL [Phase 4]
Phase 4 trial evaluating the OR Regimen for relapsed/refractory marginal zone lymphoma is currently recruiting. This study investigates a se…
-
CLINICAL_TRIALS research · 2024-05-23Clinical Trial Update: BCL6-rearrangements Implications in Non-Hodgkin Lymphomas.
This clinical trial update discusses the implications of BCL6 rearrangements across non-Hodgkin lymphomas, including follicular lymphoma, ma…
-
CLINICAL_TRIALS research · 2017-08-29Clinical Trial Update: Blood Immunophenotyping in Staging of Indolent B-cell Lymphomas V1.0
This clinical trial update reports on blood immunophenotyping techniques to aid staging of indolent B-cell lymphomas, including Follicular L…